Güney Ercihan, Cağli Sedat, Yüce Imdat
Department of Otolaryngology, Medicine Faculty of Erciyes University, Kayseri, Turkey.
Kulak Burun Bogaz Ihtis Derg. 2009 Jan-Feb;19(1):45-54.
Cancer is a disease the incidence of which rises with age. Given that the risk of developing cancer increases with advancing age, a growing number of elderly patients will need treatment for cancer in the future, and head and neck surgeons are increasingly being faced with therapeutic dilemmas regarding this age group. Related publications show that older patients are less likely than younger patients to receive standard treatment. Therapeutical planning must be based not only on tumor characteristics, but also on the physiological, rather than the chronological, age of the patient. Comorbidity is the most important factor in less intensively treatment of elderly patients. Complete geriatric assessment and a multidisiclinary approach are the crucial points. Surgeons, radiation therapy specialists, medical oncologists and geriatricians must actively cooperate in this setting. Recruitment of elderly cancer patients to more clinical trials is needed to enhance our knowledge and to offer optimum treatment to this unique subgroup.
癌症是一种发病率随年龄增长而上升的疾病。鉴于患癌风险会随着年龄的增长而增加,未来将有越来越多的老年患者需要接受癌症治疗,而头颈外科医生正日益面临针对这一年龄组的治疗困境。相关出版物表明,老年患者比年轻患者接受标准治疗的可能性更小。治疗计划不仅必须基于肿瘤特征,还应基于患者的生理年龄而非实际年龄。合并症是老年患者接受不太强化治疗的最重要因素。全面的老年医学评估和多学科方法是关键所在。在这种情况下,外科医生、放射治疗专家、肿瘤内科医生和老年病科医生必须积极合作。需要招募更多老年癌症患者参与临床试验,以增进我们的了解,并为这一独特的亚组提供最佳治疗。